NCT03570112View on ClinicalTrials.gov

Transmission of Chronic Hepatitis C in Pregnancy

CompletedOBSERVATIONAL
Enrollment

40

Participants

Timeline

Start Date

June 8, 2018

Primary Completion Date

November 22, 2022

Study Completion Date

February 27, 2023

Conditions
Hepatitis CPregnancy ComplicationsVertical Disease Transmission
Interventions
DRUG

SOF/VEL- sofosbuvir 400mg and velpatasvir 100mg

sofosbuvir 400mg and velpatasvir 100mg once daily for 12 weeks

Trial Locations (1)

45219

Lindner Research Center at the Christ hospital, Cincinnati

Sponsors

Collaborators (1)

Gilead Sciences
All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

The Christ Hospital

OTHER